Hair Loss, ‘Ozempic Face,’ and Other GLP-1 Side Effects: What’s Actually Happening in Your Body
I’m an emergency and Family Medicine physician in Chattanooga, Tennessee, and founder of Summit Metabolic Health. I read every patient chart personally. This article reports on a topic patients keep asking about — it is education, not an endorsement.
Scroll through any GLP-1 discussion forum and the comment threads about side effects usually outpace the ones celebrating weight loss. Hair loss, GI upset, facial changes, and the occasional lightheaded episode after an injection generate real conversation because people want to understand what’s happening to their bodies. That’s a reasonable thing to want. Here’s the physiology behind the most-discussed effects, and why the way a medication is dosed and monitored matters.
GI Symptoms: The Mechanism Is the Point
Nausea, bloating, and changes in bowel habits are the most common GLP-1 side effects, and they’re not incidental — they’re tied directly to how the medication works. Semaglutide and tirzepatide slow gastric emptying, which is part of why appetite decreases. When the dose increases faster than the digestive system adjusts, GI symptoms tend to spike. This is exactly why titration schedules exist: slower increases give the gut time to adapt.
Hair Loss: A Downstream Effect of Rapid Weight Loss
Hair loss on GLP-1 medications is rarely caused by the drug itself. It’s more often telogen effluvium, a temporary shedding pattern that can follow any period of rapid weight loss, caloric restriction, or physiologic stress — the same phenomenon seen after bariatric surgery, illness, or crash diets. Hair follicles get pushed into a resting phase and shed a few months later. It’s unsettling to notice, but it’s typically temporary and tends to resolve as weight stabilizes and nutrient intake stays adequate.
“Ozempic Face”: Fat Loss Doesn’t Skip the Face
The term describes something real: facial volume loss that can make weight loss look more pronounced in the face than elsewhere, sometimes accentuating fine lines. Facial fat pads shrink along with fat elsewhere in the body — the medication isn’t targeting the face specifically, it’s just that facial changes are the most visible to us and to others. Rate of weight loss and starting body composition both influence how noticeable this is.
Vasovagal Reactions: Less Common, Still Worth Knowing About
Some patients report brief lightheadedness or a fainting sensation around injections. This is usually a vasovagal response — a nervous system reflex triggered by needle anxiety, dehydration, or rapid changes in blood pressure — rather than a direct drug effect. It’s more common early in treatment and tends to fade with reassurance and technique (sitting during injection, staying hydrated, eating beforehand).
Why Titration and Monitoring Exist
None of these side effects are reasons to avoid GLP-1 therapy outright, but they are reasons dosing should be individualized rather than rushed. At Summit, semaglutide and tirzepatide are titrated based on how each patient is responding — not a fixed calendar. That means slowing down if GI symptoms are prominent, checking in on hydration and nutrition to support hair and skin, and adjusting the plan rather than pushing through discomfort. Side effects are data. Ignoring them isn’t the goal; understanding them is.
Our physician-led team in Chattanooga can walk through titration, monitoring, and what to expect at every stage. Talk to a physician →